Trial Profile
Outcome of Three Controlled Ovarian Hyperstimulation Protocols in Poor Responding Infertility Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jan 2016
Price :
$35
*
At a glance
- Drugs Letrozole (Primary) ; Menotropin; Recombinant follicle-stimulating hormone
- Indications Infertility
- Focus Therapeutic Use
- 07 Jan 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 09 May 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 May 2015 to 1 Aug 2015.
- 09 May 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Apr 2015 to 1 Jul 2015.